These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Factors in the development of severe forms of tardive dyskinesia. Yassa R; Nair NP; Iskander H; Schwartz G Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745 [TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107 [TBL] [Abstract][Full Text] [Related]
7. Preliminary findings with regard to risk factors in the development of tardive dyskinesia [proceedings]. Kane J; Struve F; Woerner M; Weinhold P Psychopharmacol Bull; 1981 Jan; 17(1):47-9. PubMed ID: 6112775 [No Abstract] [Full Text] [Related]
8. Depression as a predictor in the development of tardive dyskinesia. Yassa R; Schwartz G Biol Psychiatry; 1984 Mar; 19(3):441-4. PubMed ID: 6144331 [No Abstract] [Full Text] [Related]
9. ECT and tardive dyskinesia: two cases and a review. Chacko RC; Root L J Clin Psychiatry; 1983 Jul; 44(7):265-6. PubMed ID: 6134719 [TBL] [Abstract][Full Text] [Related]
10. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. Glazer WM J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326 [TBL] [Abstract][Full Text] [Related]
11. Dyskinetic movement disorder among adults with mental retardation: phenomenology and co-occurrence with stereotypy. Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH Am J Ment Retard; 1996 Sep; 101(2):118-29. PubMed ID: 8883667 [TBL] [Abstract][Full Text] [Related]
12. [Tardive dyskinesia: an increased risk of neuroleptics in elderly women]. Jessurun AY; Stek ML Tijdschr Gerontol Geriatr; 1995 Oct; 26(5):197-9. PubMed ID: 8750979 [TBL] [Abstract][Full Text] [Related]
13. [Effects and complications of neuroleptics (110 hospitalizations in neurology)]. Destee A; Montagne B; Rousseaux M; Petit H; Warot P Lille Med; 1980; 25(6):291-5. PubMed ID: 6105602 [No Abstract] [Full Text] [Related]
14. The clinical association of tardive dyskinesia and drug-induced parkinsonism. Wolf ME; Chevesich J; Lehrer E; Mosnaim AD Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032 [No Abstract] [Full Text] [Related]
15. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study. Raja M; Azzoni A Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708 [TBL] [Abstract][Full Text] [Related]
17. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Nasrallah HA Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454 [TBL] [Abstract][Full Text] [Related]
18. Treatment of tardive dyskinesia with propranolol. Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534 [TBL] [Abstract][Full Text] [Related]
19. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics. Spohn HE; Coyne L Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820 [TBL] [Abstract][Full Text] [Related]
20. [Tardive dyskinesia following after small doses of neuroleptics]. Bjørndal F; Rasmussen PT Ugeskr Laeger; 1982 Mar; 144(12):871-2. PubMed ID: 6125047 [No Abstract] [Full Text] [Related] [Next] [New Search]